ID

26231

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Third party follow-up - Repeating form (Scheduled/Dynamic visit)

Mots-clés

Versions (3)
  1. 12/10/2017 12/10/2017 -
  2. 23/10/2017 23/10/2017 -
  3. 02/01/2018 02/01/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

12 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

Anglais

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulaires  
Date of last contact attempt
Description

Date of last contact attempt

1. Date of most recent attempt to contact third party
Description

Date of last contact attempt

Type de données

date

Contact details
Description

Contact details

2. Was contact successful? (i.e. actually spoke to someone)
Description

contact successful

Type de données

boolean

If contact successful: Type of third party contact
Description

Type of third party contact

Type de données

text

Other type of third party contact
Description

Other type of third party contact

Type de données

text

Are there any new study endpoints to report?
Description

If Yes, complete SAE-EP and appropriate Endpoint forms.

Type de données

text

Date endpoint information assessed by third party
Description

Date endpoint information assessed by third party

Type de données

date

Retour au début de la page

Similar models

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Date of last contact attempt
Date of last contact attempt
Item
1. Date of most recent attempt to contact third party
date
Item Group
Contact details
contact successful
Item
2. Was contact successful? (i.e. actually spoke to someone)
boolean
Item
If contact successful: Type of third party contact
text
Type of third party contact
Code List
If contact successful: Type of third party contact
CL Item
Investigative site staff (4)
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Friend or neighbor (5)
CL Item
Other (OT)
Other type of third party contact
Item
Other type of third party contact
text
Item
Are there any new study endpoints to report?
text
new study endpoints
Code List
Are there any new study endpoints to report?
CL Item
Unknown (Third party not able to find out if subject did or did not have new study endpoint, or the only information available is vital status "death" without details) (U)
CL Item
No (Third party able to confirm no new study endpoints) (N)
CL Item
Yes (Third party able to confirm the presence of new study endpoints. Do not select this option if the only information available is vital status "death" without details) (Y)
Date endpoint information assessed by third party
Item
Date endpoint information assessed by third party
date
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial